Press Releases

Movano Inc. to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021

Movano Inc. (NASDAQ:MOVE) will report second quarter 2021 financial and operating results on Thursday, August 12, 2021. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 2:00 p.m. PDT.

Movano Conducts IRB-Approved Clinical Study with Prototype Blood Pressure Device

Movano Inc. (NASDAQ:MOVE) used its non-invasive, iPhone-sized prototype device to collect pulse pressure waveform data from 45 external participants in an IRB-approved study in the Movano Clinical Lab.

Movano Inc. Set to Join Russell Microcap Index

Movano Inc. (NASDAQ:MOVE) is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28.

Movano Inc. Provides Business Update and Reports First Quarter 2021 Financial Results

Movano Inc. (NASDAQ:MOVE) reported financial results for the three months ending March 31, 2021 and provided a business update.

Movano Inc. to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021

Movano Inc. (NASDAQ:MOVE) today announced that it will report first quarter 2021 financial and operating results on Thursday, May 13, 2021.

Movano Inc. Appoints Medtech Industry Veteran John Mastrototaro, PhD, as CEO

Movano Inc. (NASDAQ:MOVE), announced current Director, Dr. John Mastrototaro, will join the Company as CEO, effective April 1, 2021.

Movano Inc. Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option

Movano Inc. (NASDAQ:MOVE), has closed its previously announced initial public offering of 8,500,000 shares of its common stock at a public offering price of $5.00 per share.

Movano Inc. Prices $42.5 Million Public Offering of Common Stock

Movano Inc. (NASDAQ:MOVE) announced the pricing of its initial public offering of 8,500,000 shares of its common stock at a public offering price of $5.00 per share.

GLOBALFOUNDRIES and Movano Inc. Partner to Advance Needle-Free Continuous Glucose Monitoring Technology

Manufactured on GF’s 22FDX platform, Movano’s radio frequency-enabled solution will help individuals to manage their glucose levels anywhere, anytime

Movano Inc. Closes Bridge Financing Round at $12.5M

After announcing $10M in bridge funding in July, the company raised an additional $2.5M to progress the development of its wearable non-invasive continuous glucose monitor

Movano Inc. Exits Stealth Mode and Secures $10M in Additional Funding to Transform Glucose Monitoring with Non-Invasive Technology

Company’s needle-free wearable technology will provide painless, real-time glucose readings at the glance of a wrist

Featured In